Case Report

Severe Diabetic Ketoacidosis and Coronavirus 2019 (COVID-19) Infection led to Diagnosis of Autoimmune Polyglandular Syndrome

Abstract

To this day, millions of people in the world have been diagnosed with corona virus 2019 (COVID-19). This disease cannot only lead to higher mortality rates among those with underlying Diabetes Mellitus (DM), but also may trigger DM in susceptible patients. Therefore, incidence of new-onset DM increased during the pandemic as a result; treatment of patients with diabetes and COVID-19 is important and needs further investigations. Here, we report a 27-year- old woman with past medical history of premature ovarian failure (POF) since14 years ago, who initially presented with severe diabetic ketoacidosis (DKA) which was triggered by COVID-19 and later through her lab results hypoparathyroidism was also detected. She was treated for DKA and COVID-19 Infection concomitantly, and she was also diagnosed with autoimmune polyglandular syndrome due to her multiple autoimmune endocrine organ involvements. 

[1] Branswell H JA. WHO declares the coronavirus outbreak a pandemic 2020. 2020.
[2] Baradaran A, Ebrahimzadeh MH, Baradaran A, Kachooei AR. Prevalence of comorbidities in COVID-19 patients: A systematic review and meta-analysis. Archives of Bone and Joint Surgery. 2020;8(Suppl 1):247.
[3] Rabizadeh S, Hajmiri M, Rajab A, Emadi Kouchak H, Nakhjavani M. Severe diabetic ketoacidosis and coronavirus disease 2019 (COVID- 19) infection in a teenage patient with newly diagnosed diabetes. J Pediatr Endocrinol Metab. 2020:1241-3.
[4] Bornstein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld AL, et al. Practical recommendations for the management of diabetes in patients with COVID-19. The lancet Diabetes & endocrinology. 2020..
[5] Yang J-K, Lin S-S, Ji X-J, Guo L-M. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta diabetologica. 2010;47(3):193-9.
[6] Reddy PK, Kuchay MS, Mehta Y, Mishra SK. Diabetic ketoacidosis precipitated by COVID-19: a report of two cases and review of literature. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;14(5):1459-62.
[7] Carey IM, Critchley JA, DeWilde S, Harris T, Hosking FJ, Cook DG. Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study. Diabetes care. 2018;41(3):513-21.
[8] Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: A review of pathogenesis. Indian journal of endocrinology and metabolism. 2012;16(Suppl1): S27.
[9] Husebye ES, Anderson MS, Kämpe O. Autoimmune Polyendocrine Syndromes. The New England journal of medicine. 2018;378(12):1132-41
[10] Kahaly GJ, Frommer L. Polyglandular autoimmune syndromes. J Endocrinol Invest. 2018;41(1):91-8
Files
IssueVol 8 No 1 (2023): Janyary-February QRcode
SectionCase Report(s)
DOI https://doi.org/10.18502/crcp.v8i1.13092
Keywords
COVID-19 Diabetic ketoacidosis Newly diagnosed diabetes Autoimmune polyglandular syndrome Case Report

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Tavakoli M, Rabizadeh S, Seifouri S, Esteghamati A, Nakhjavani M. Severe Diabetic Ketoacidosis and Coronavirus 2019 (COVID-19) Infection led to Diagnosis of Autoimmune Polyglandular Syndrome. CRCP. 2023;8(1):16-20.